316 related articles for article (PubMed ID: 30833929)
1. Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy.
Longo M; Bellastella G; Maiorino MI; Meier JJ; Esposito K; Giugliano D
Front Endocrinol (Lausanne); 2019; 10():45. PubMed ID: 30833929
[TBL] [Abstract][Full Text] [Related]
2. Management of hypoglycemia in older adults with type 2 diabetes.
Freeman J
Postgrad Med; 2019 May; 131(4):241-250. PubMed ID: 30724638
[TBL] [Abstract][Full Text] [Related]
3. Glycemic targets and medication limitations for type 2 diabetes mellitus in the older adult.
Thompson AM; Linnebur SA; Vande Griend JP; Saseen JJ
Consult Pharm; 2014 Feb; 29(2):110-23. PubMed ID: 24513421
[TBL] [Abstract][Full Text] [Related]
4. Combination Glucose-Lowering Therapy Plans in T2DM: Case-Based Considerations.
Blonde L; Dipp S; Cadena D
Adv Ther; 2018 Jul; 35(7):939-965. PubMed ID: 29777519
[TBL] [Abstract][Full Text] [Related]
5. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.
Lau DC; Teoh H
Can J Diabetes; 2015 Dec; 39 Suppl 5():S148-54. PubMed ID: 26654858
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase-4 inhibitors in the elderly: more benefits or risks?
Paolisso G; Monami M; Marfella R; Rizzo MR; Mannucci E
Adv Ther; 2012 Mar; 29(3):218-33. PubMed ID: 22411425
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.
Thrasher J
Am J Med; 2017 Jun; 130(6S):S4-S17. PubMed ID: 28526182
[TBL] [Abstract][Full Text] [Related]
8. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
9. Insulin use in elderly adults: risk of hypoglycemia and strategies for care.
Ligthelm RJ; Kaiser M; Vora J; Yale JF
J Am Geriatr Soc; 2012 Aug; 60(8):1564-70. PubMed ID: 22881394
[TBL] [Abstract][Full Text] [Related]
10. Diabetes Treatment in the Elderly: Incorporating Geriatrics, Technology, and Functional Medicine.
Valencia WM; Botros D; Vera-Nunez M; Dang S
Curr Diab Rep; 2018 Sep; 18(10):95. PubMed ID: 30187176
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.
Thrasher J
Am J Cardiol; 2017 Jul; 120(1S):S4-S16. PubMed ID: 28606343
[TBL] [Abstract][Full Text] [Related]
12. Beyond metformin: initiating combination therapy in patients with type 2 diabetes mellitus.
Goldman-Levine JD
Pharmacotherapy; 2011 Dec; 31(12 Suppl):44S-53S. PubMed ID: 22122222
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic management of the older patient with type 2 diabetes mellitus.
Neumiller JJ; Setter SM
Am J Geriatr Pharmacother; 2009 Dec; 7(6):324-42. PubMed ID: 20129254
[TBL] [Abstract][Full Text] [Related]
14. [Attention to the use of oral anti-diabetic medication in older adults with type 2 diabetes].
Jojima T; Aso Y
Nihon Rinsho; 2013 Nov; 71(11):1987-92. PubMed ID: 24397171
[TBL] [Abstract][Full Text] [Related]
15. Managing type 2 diabetes: going beyond glycemic control.
Stolar MW; Hoogwerf BJ; Gorshow SM; Boyle PJ; Wales DO
J Manag Care Pharm; 2008 Jun; 14(5 Suppl B):s2-19. PubMed ID: 18597582
[TBL] [Abstract][Full Text] [Related]
16. Challenges Related to Glycemic Control in Type 2 Diabetes Mellitus Patients.
Kheirandish M; Mahboobi H; Yazdanparast M; Kamal MA
Curr Drug Metab; 2017; 18(2):157-162. PubMed ID: 28093996
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of diabetes in elderly people.
Paolisso G
Acta Biomed; 2010; 81 Suppl 1():47-53. PubMed ID: 20518191
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of diabetes in metabolic syndrome].
Pelikánova T
Vnitr Lek; 2009; 55(7-8):637-45. PubMed ID: 19731868
[TBL] [Abstract][Full Text] [Related]
19. Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications.
Eleftheriadou I; Grigoropoulou P; Liberopoulos E; Liatis S; Kokkinos A; Tentolouris N
Curr Med Chem; 2018; 25(13):1549-1566. PubMed ID: 28554326
[TBL] [Abstract][Full Text] [Related]
20. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
